EMERGENCY RESPONSE FRAMEWORK - WHO
(e.g. dengue, plague, yellow fever), or the environment (e.g. radio-nuclear releases, chemical spills or other contamination). In all types of emergencies, the poorest and most vulnerable people suffer disproportionately. These negative impacts are complicated by the enormity of the resulting economic costs, averaging over US$100 billion per year.
Download EMERGENCY RESPONSE FRAMEWORK - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
ENERGY SAVING PLAN - Environment Bureau
www.enb.gov.hkFor Hong Kong’s Built Environment 2015~2025+ Environment Bureau in collaboration with Development Bureau Transport and Housing Bureau May 2015. CONTENTS Message from the Chief Executive Special Messages from Principal Offi cials Preface Summary of Energy Saving Plan for Hong Kong 2015~2025+
A Universal Design Approach 1
universaldesign.ieCreating an environment that can be used by all people, regardless of their age, size, disability or ability. The National Disability Authority’s Centre for Excellence in Universal Design has a statutory role to promote the achievement of excellence in universal design in: • the design of the built and external environment
Benefits from the environment
www.environment.gov.scotDecisions about managing our environment often fail to take account of nature’s ability to provide these benefits. Managing the environment in ways that provide some benefits can sometimes reduce its ability to provide others. By managing the environment well we can provide many more benefits and greatly improve our quality of life.
Accessibility Code For The Built Environment
www.dda.gov.aeAccessibility Code For The Built Environment Accessibility Code For The Built Environment User Journey Mapping - creates a mental model of users’ experience of a typical journey from a starting point to an end point via various modes of movement along …